menu
    • menu

    Company profile for Aiolos Bio

    NEW Drugs in Dev: 1
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Aiolos Bio, we are dedicated to revolutionizing the treatment landscape for respiratory disease and other immune conditions. We’re on a mission to reimagine therapies that bring hope and relief to patients and caregivers alike. Aiolos Bio is an accomplished team of seasoned drug developers with decades of industry experience and operational leadership. With over 30 FDA approvals, we’ve successfully developed and launche...
    At Aiolos Bio, we are dedicated to revolutionizing the treatment landscape for respiratory disease and other immune conditions. We’re on a mission to reimagine therapies that bring hope and relief to patients and caregivers alike. Aiolos Bio is an accomplished team of seasoned drug developers with decades of industry experience and operational leadership. With over 30 FDA approvals, we’ve successfully developed and launched products for a range of immune conditions, including asthma, rheumatoid arthritis, IPF, and more.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aiolos BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Francisco, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aiolosbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aiolos-bio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GSK boosts respiratory portfolio with $1.4 bln Aiolos Bio deal
    GSK boosts respiratory portfolio with $1.4 bln Aiolos Bio deal

    10 Jan 2024

    // REUTERS

    https://www.reuters.com/markets/deals/gsk-acquire-aiolos-bio-14-bln-deal-2024-01-09/

    REUTERS
    10 Jan 2024
    Share Share
    Aiolos Bio Strengthens and Expands Leadership Team with Key Appointments
    Aiolos Bio Strengthens and Expands Leadership Team with Key Appointments

    12 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231212153871/en

    BUSINESSWIRE
    12 Dec 2023
    Share Share
    Aiolos Bio launches with $245M Series A, chasing one of asthma’s hottest targets
    Aiolos Bio launches with $245M Series A, chasing one of asthma’s hottest targets

    24 Oct 2023

    // Andrew Dunn ENDPTS

    https://endpts.com/aiolos-bio-launches-with-245m-series-a-chasing-one-of-asthmas-hottest-targets/

    Andrew Dunn ENDPTS
    24 Oct 2023
    Share Share
    Aiolos Bio launches with $245M to advance severe asthma med
    Aiolos Bio launches with $245M to advance severe asthma med

    24 Oct 2023

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/aiolos-bio-launches-ex-gyroscope-ceo-helm-nearly-250m-advance-severe-asthma-med

    Max Bayer FIERCE BIOTECH
    24 Oct 2023
    Share Share
    Aiolos Bio Launches with $245 Million Series A Investment
    Aiolos Bio Launches with $245 Million Series A Investment

    24 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231024577944/en

    BUSINESSWIRE
    24 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search